Home » Tuberculosis
You are browsing entries filed in “Tuberculosis”
By Kaiser GH Update
GlobalPost’s “Global Pulse” blog reports on a potential public-private partnership that aims to bring tuberculosis (TB) vaccine trials to the gold mines of Southern Africa, where, “[f]or every 100,000 workers …, 3,000 have tuberculosis, and many have often-fatal, drug-resistant strains of TB.” The blog writes that mining company “Anglo American announced Tuesday at the GBCHealth Conference [in New York] that it has agreed in principle to make its mines available for TB vaccine trials organized by Aeras, a non-profit that has 12 TB vaccine candidates now in various stages of research,” noting, “No formal agreement has been reached, but Anglo American’s spokesman vowed to make it happen.”
May 17th, 2012 | Posted in Kaiser's Global Health Update,Tuberculosis | Read More »
By SciDev.net
Vietnam is seeking help from experts in Australia to reduce its levels of tuberculosis, one of the highest in Asia.
May 17th, 2012 | Posted in Infectious Disease,Tuberculosis,Uncategorized | Read More »
By Kaiser GH Update
“This year marks the 10th anniversary of the Global Fund to Fight AIDS, Tuberculosis and Malaria, the world’s most powerful tool in the fight against the three pandemics,” Jonathan Klein, co-founder and CEO of Getty Images, Inc., writes in this post in the Huffington Post Blog, adding, “Since 2002, the Global Fund has saved and improved millions of lives.” Klein notes the Board of the Global Fund convened in Geneva, Switzerland, for its 26th meeting last week, where Board members “discussed progress to date on the current transformation of the Global Fund from emergency response to long-term sustainability.”
May 16th, 2012 | Posted in Aid,Kaiser's Global Health Update,Malaria,Tuberculosis | Read More »
By PSIHealthyLives
May 14, 2012 The WHO says that 1/3 of the world’s population is suffering from TB and warns that the world is losing its progress against the spread of the illness. Extreme drug-resistant strains of TB have now been found in 70 countries, and doctors in India reported four patients this year, who did not respond to any drugs at all. Doctors in Iran and Italy have also found patients who are apparently resistant to all drugs. “What we are seeing worldwide is the emergence of strains of the bacillus causing tuberculosis that are resistant to most of the drugs we have available,” the Independent quoted Mario Raviglione, director of the WHO’s Stop TB campaign, as saying. The rate of TB deaths had declined drastically – by 40 per cent between 1990 and 2000 – after a worldwide health campaign, which was particularly successful in China
May 16th, 2012 | Posted in Tuberculosis | Read More »
By Kaiser GH Update
“A third of the world’s population is carrying tuberculosis [TB], and the disease could become incurable if governments fail to act, the World Health Organization (WHO) has warned,” noting that a “[l]ack of funding for public health programs, the sale of inaccurate blood tests and the misuse of drugs, particularly in the private health sector, are hampering the fight against the disease and leading to drug resistance,” the Independent reports. “The rate of TB deaths had declined dramatically — by 40 percent between 1990 and 2000 — after a worldwide health campaign, which was particularly successful in China,” but “the emergence of drug-resistant strains threatens to halt progress and jeopardizes the WHO’s goal of eradicating the disease as a public health problem by 2050,” the newspaper writes, noting, “Two billion people are carriers of the TB bacillus” globally.
May 14th, 2012 | Posted in Kaiser's Global Health Update,Tuberculosis | Read More »
By Kaiser GH Update
After announcing it plans to spend an additional $1.67 million over the next two years, the Global Fund to Fight AIDS, Tuberculosis and Malaria Board on Friday at the end of its 26th meeting in Geneva said (.pdf) its “secretariat will present at an upcoming board meeting in September new funding models drafted in consultation with recipient countries and other stakeholders,” and the board will “announce funding decisions no later than April 2013,” Devex reports.
May 14th, 2012 | Posted in Aid,Kaiser's Global Health Update,Malaria,Tuberculosis | Read More »
By PLoS Medicine Blog
Image Credit: Charles Williams Three new articles published this week in PLoS Medicine: A time-series study conducted by Keith Hawton and colleagues reports on the links between withdrawal of the analgesic co-proxamol and subsequent prescribing and deaths associated with analgesic poisoning. Rajaie Batniji and Eran Bendavid dispute recent suggestions that health aid to developing countries leads to a displacement of government spending and instead argue that current evidence about aid displacement cannot be used to guide policy. Katherine Todrys and Joseph Amon argue for criminal justice system reforms in sub-Saharan Africa to reduce HIV and TB transmission in prisons and to guarantee detainees’ human rights and health. Remember you can comment on, annotate and rate any PLoS Medicine article and see the views, citations and other indications of impact of an article on that articles metrics tab.
May 10th, 2012 | Posted in Aid,Human Rights,Tuberculosis,Uncategorized | Read More »
By Kaiser GH Update
The Global Fund to Fight AIDS, Tuberculosis and Malaria “expects to have an additional $1.6 billion to fund projects in 2012-2014, [the fund's General Manager Gabriel Jaramillo] said on Wednesday, a turnaround from a funding freeze last year,” Reuters reports (Miles, 5/9). “The new funds are a result of ‘strategic decisions made by the Board, freeing up funds that can be invested in countries where there is the most pressing demand,’ a statement by the fund said,” according to PlusNews (5/10). “The money includes funds from new donors, from traditional donors who are advancing their payments or increasing contributions and from some donors, such as China, that have offered to support projects in their own country to free up cash for more pressing needs elsewhere, Jaramillo said,” Reuters notes (5/9). “This forecast is better than expected, and it comes from the fantastic response we are getting to our transformation,” Jaramillo said, adding, “But we need more to get the job done. Countries that implement our grants are saving more and more people, but demand for services is still enormous,” according to the statement (5/9).
May 10th, 2012 | Posted in Aid,Kaiser's Global Health Update,Malaria,Tuberculosis | Read More »
By ScienceSpeaks
Aeras and the Infectious Disease Research Institute (IDRI) – two non-profit product development partnerships (PDPs) – announced Wednesday they will be joining together to develop IDRI’s novel tuberculosis (TB) vaccine candidate ID93/GLA-SE. The compound contains an IDRI-designed recombinant fusion-protein antigen (a protein substance foreign to the body that stimulates the immune system’s production of antibodies (Read more…)
May 10th, 2012 | Posted in Infectious Disease,Tuberculosis,Vaccinations | Read More »
By Kaiser GH Update
U.S. Ambassador to Nigeria Terence McCulley on Tuesday in Abuja, Nigeria, launched a five-year, $224 million USAID program, titled Strengthening Integrated Delivery of HIV/AIDS Services (SIDHAS), that aims to “increas[e] access to high-quality comprehensive HIV/AIDS and tuberculosis prevention, treatment, care and related services through improved efficiencies in service delivery,” the Daily Trust reports (Odeyemi/Odafor, 5/8).
May 9th, 2012 | Posted in Aid,Delivery,HIV/AIDS,Kaiser's Global Health Update,Tuberculosis | Read More »
By Kaiser GH Update
In a “wide-ranging,” two-part interview with AllAfrica.com, Unni Karunakara, the international president of Medecins Sans Frontieres (MSF), “spoke about the values that underpin the work of MSF, the organization’s culture and its passion for principled humanitarian action,” the news service writes. “Humanitarian aid has come a long way in the last 40 years, says … Karunakara, but he warns that important health care gains made in the last decade may be reversed if funding is not maintained,” the news service notes. In part one of the interview, Karunakara discusses “gains made in reducing medicine costs and providing treatment for AIDS, tuberculosis and malaria,” as well as “the challenges MSF faces in remaining independent and principled in conflict situations.” In part two of the interview, “he looks at the future of MSF in a changing world” (Valentine, 5/7).
May 8th, 2012 | Posted in Aid,Kaiser's Global Health Update,Malaria,Tuberculosis | Read More »
By Kaiser GH Update
The Global Fund to Fight AIDS, Tuberculosis and Malaria “is cutting its workforce and tightening its focus on 20 countries hardest hit by AIDS, tuberculosis and malaria,” Reuters reports. Gabriel Jaramillo, who took over as general manager of the fund in January, “said in a statement that the fund had completed a reorganization that would rebalance its workforce with 39 percent more people managing grants and 38 percent fewer in support roles,” the news service notes.
May 2nd, 2012 | Posted in Aid,Kaiser's Global Health Update,Malaria,Tuberculosis | Read More »
By Kaiser GH Update
“If we needed more evidence that the funding cuts at the Global Fund to Fight AIDS, Tuberculosis and Malaria were going to be detrimental to people’s lives, a new study … makes it clear: Providing funding to fight malaria makes malaria go away,” Kolleen Bouchane, director of ACTION, a global partnership of health advocacy organizations, writes in the Huffington Post’s “Impact” blog. “The authors write that as substantial new financial resources have become available to fight malaria since 2000, malaria has decreased considerably in many parts of the world,” she continues, adding, “But in the past, malaria has returned when malaria control programs have been weakened — and they’ve usually been weakened when resources dried up.”
April 30th, 2012 | Posted in Aid,Kaiser's Global Health Update,Malaria,Tuberculosis | Read More »
By Kaiser GH Update
Nature Outlook examines the fight against malaria in Uganda. “Uganda’s tragic failure to abate malaria has numerous political, geographic, economic and social factors — and illustrates the reality that it takes more than scientific breakthroughs and cheap drugs to solve this persistent menace,” according to the article. Nature describes how a primarily rural population, “[f]unding bottlenecks, inefficient procurement processes, transportation problems,” drug stock-outs, and a lack of health care workers affects access to care and treatment for malaria, as well as how aid from the Global Fund to Fight AIDS, Tuberculosis, and Malaria, the Bill & Melinda Gates Foundation, the President’s Malaria Initiative, and other donors is supporting programs to build sustainable solutions to fighting the disease (Newmen, 4/25).
April 26th, 2012 | Posted in Kaiser's Global Health Update,Malaria,Tuberculosis | Read More »
